The Latest Breaking News from FDA

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

The FDA said Monday it will perform a speedy review of Sarepta Therapeutics' muscular dystrophy gene therapy, and SRPT stock jumped.

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough

November is Lung Cancer Awareness month. Lung cancer is the most common cancer worldwide, with more than 2.1 million cases, according to the American Lung Association.

Conservative Christian group takes aim at abortion drug that is also used to treat miscarriages

AUSTIN, Texas — Abortion opponents on Friday asked a federal court to yank federal approval of a pill used to end pregnancies.